arrow
J

Jin Sun Lee

University of California System
H指数:31
被引数:3,386

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial

Amivantamab联合lazertinib与osimertinib作为EGFR突变的晚期非小细胞肺癌 (NSCLC) 患者的一线治疗: MARIPOSA,一项III期,全球,随机,对照试验的主要结果

2023-10-0141
OA
Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2

Amivantamab联合lazertinib治疗不包括外显子20插入突变的非典型表皮生长因子受体 (EGFR) 突变患者: CHRYSALIS-2的初步结果

2022-11-012
OAAI
Nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 part 1: Efficacy by KRAS, STK11, and KEAP1 mutation status
2021-12-0114
OA